Digital platform aims to Fine-Tune heart failure drugs after hospital stay

NCT ID NCT07352891

Recruiting now Disease control Sponsor: Beijing Anzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a digital remote-management platform can help doctors better adjust heart failure medications after patients leave the hospital. About 252 adults with heart failure and reduced pumping function will use the platform to report symptoms and vital signs, with an algorithm suggesting medication changes. The goal is to see if this approach leads to more optimized drug therapy compared to usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE WITH REDUCED EJECTION FRACTION

Contacts and locations

Locations

Beijing Anzhen Hospital, Capital Medical University, Beijing, China
RECRUITING

Beijing, China
Beijing Tongren Hospital, Capital Medical University, Beijing, China
RECRUITING

Beijing, China
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
NOT_YET_RECRUITING

Shanghai, China
The First Affiliated Hospital of Dalian Medical University, Dalian, China
RECRUITING

Dalian, China
The First Hospital of Jilin University, Changchun, China
RECRUITING

Jilin City, China
The Second Affiliated Hospital of Nanchang University, Nanchang, China
NOT_YET_RECRUITING

Nanchang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.